| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | H1-10 TNRC18 HMGA2 STAG1 UBTF NOC3L SMARCA2 PUS1 MLLT1 CHD1 CHD2 CHD4 HMGA1 KDM6B MECP2 HNRNPU | 5.39e-08 | 739 | 83 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.31e-07 | 37 | 83 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | KMT2C ABL1 ZBTB32 HMGA2 TCF20 SMARCA2 PUS1 CHD4 HMGA1 SRCAP MECP2 HNRNPU HDGF | 5.28e-07 | 562 | 83 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | HMGA2 SMARCA2 PUS1 CHD1 CHD2 CHD4 HMGA1 SRCAP NOP2 ALKBH5 DHX8 FTSJ3 | 1.39e-05 | 645 | 83 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | KMT2C SORBS2 ABL1 ZBTB32 HMGA2 TCF20 SMARCA2 PUS1 SORBS1 CHD4 HMGA1 SRCAP ALKBH5 MECP2 HNRNPU HDGF | 1.96e-05 | 1160 | 83 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 2.50e-05 | 41 | 83 | 4 | GO:0000217 | |
| GeneOntologyMolecularFunction | helicase activity | 5.10e-05 | 158 | 83 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 6.93e-05 | 167 | 83 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.10e-04 | 262 | 83 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | KMT2C SORBS2 ABL1 ZBTB32 HMGA2 TCF20 SMARCA2 PUS1 SORBS1 CHD4 HMGA1 SRCAP ALKBH5 MECP2 HNRNPU HDGF | 1.27e-04 | 1356 | 83 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.88e-04 | 127 | 83 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.68e-04 | 303 | 83 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.85e-04 | 229 | 83 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 4.70e-04 | 8 | 83 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | 5'-deoxyribose-5-phosphate lyase activity | 4.70e-04 | 8 | 83 | 2 | GO:0051575 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 5.68e-04 | 39 | 83 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 7.52e-04 | 10 | 83 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 7.52e-04 | 10 | 83 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | histone binding | 8.30e-04 | 265 | 83 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 8.66e-04 | 45 | 83 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | minor groove of adenine-thymine-rich DNA binding | 9.16e-04 | 11 | 83 | 2 | GO:0003680 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 9.16e-04 | 11 | 83 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.01e-03 | 614 | 83 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | DNA-(apurinic or apyrimidinic site) endonuclease activity | 1.50e-03 | 14 | 83 | 2 | GO:0003906 | |
| GeneOntologyMolecularFunction | snRNA binding | 1.72e-03 | 57 | 83 | 3 | GO:0017069 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.40e-03 | 441 | 83 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 2.51e-03 | 65 | 83 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 2.62e-03 | 66 | 83 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 2.62e-03 | 66 | 83 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 2.74e-03 | 67 | 83 | 3 | GO:0031492 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.77e-03 | 140 | 83 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | four-way junction DNA binding | 2.79e-03 | 19 | 83 | 2 | GO:0000400 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 3.09e-03 | 20 | 83 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | DNA binding, bending | 3.09e-03 | 20 | 83 | 2 | GO:0008301 | |
| GeneOntologyMolecularFunction | transcription factor binding | 4.01e-03 | 753 | 83 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | rRNA methyltransferase activity | 4.44e-03 | 24 | 83 | 2 | GO:0008649 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a rRNA | 4.81e-03 | 25 | 83 | 2 | GO:0140102 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 5.76e-03 | 172 | 83 | 4 | GO:0008757 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | H1-10 KMT2C HMGA2 KMT2B ARID4A CTR9 SMARCA2 CHD1 CHD2 CHD4 HMGA1 GNAS KDM6B SRCAP MECP2 HNRNPU HDGF | 2.29e-09 | 741 | 79 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H1-10 KMT2C HMGA2 KMT2B ARID4A CTR9 UBTF SMARCA2 CHD1 CHD2 CHD4 HMGA1 GNAS KDM6B SRCAP MECP2 HNRNPU HDGF | 3.09e-08 | 999 | 79 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | H1-10 KMT2C HMGA2 KMT2B ARID4A CTR9 SMARCA2 CHD1 CHD2 CHD4 HMGA1 GNAS KDM6B SRCAP MECP2 HNRNPU HDGF | 3.80e-08 | 896 | 79 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | KMT2C NAMPT PAXBP1 ABL1 HMGA2 TCF20 ARID4A LMX1A CTR9 SMARCA2 PUS1 E2F7 HMGA1 KDM6B TEF MECP2 LARP7 HNRNPU HDGF MYBL2 | 1.86e-07 | 1390 | 79 | 20 | GO:0045944 |
| GeneOntologyCellularComponent | nuclear body | NAMPT ABL1 TCF20 STAG1 INTS13 CTR9 SCN1A SURF2 NOC3L E2F7 SRCAP ALKBH5 REXO1 PRX HNRNPU DHX8 | 1.38e-06 | 903 | 90 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FANCE KMT2C KMT2B ARID4A INTS13 CTR9 RNPC3 SMARCA2 E2F7 MLLT1 AFF1 CHD4 HMGA1 KDM6B SRCAP LARP7 HNRNPU DHX8 MYBL2 | 5.08e-06 | 1377 | 90 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | FANCE H1-10 ZBTB32 HMGA2 STAG1 ARID4A LMX1A CTR9 SMARCA2 ANKRD11 E2F7 CHD1 CHD2 CHD4 HMGA1 SRCAP TEF MECP2 | 5.09e-05 | 1480 | 90 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | senescence-associated heterochromatin focus | 1.09e-04 | 4 | 90 | 2 | GO:0035985 | |
| GeneOntologyCellularComponent | nuclear speck | 5.42e-04 | 431 | 90 | 8 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear chromosome | 8.06e-04 | 254 | 90 | 6 | GO:0000228 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.18e-03 | 12 | 90 | 2 | GO:0044666 | |
| HumanPheno | Abnormal 5th finger morphology | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC GNAS KDM6B SRCAP MECP2 | 5.35e-08 | 509 | 31 | 15 | HP:0004207 |
| HumanPheno | Clinodactyly of the 5th finger | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 3.53e-07 | 420 | 31 | 13 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 3.62e-07 | 421 | 31 | 13 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 3.62e-07 | 421 | 31 | 13 | HP:0009179 |
| HumanPheno | Macrostomia | KMT2B STAG1 SCN1A SMARCA2 ANKRD11 PACS2 CHD2 KDM6B SRCAP LARP7 | 3.68e-07 | 220 | 31 | 10 | HP:0000181 |
| HumanPheno | Wide mouth | KMT2B STAG1 SCN1A SMARCA2 ANKRD11 PACS2 CHD2 KDM6B SRCAP LARP7 | 3.68e-07 | 220 | 31 | 10 | HP:0000154 |
| HumanPheno | Thin vermilion border | XYLT2 ABL1 HMGA2 TCF20 SCN1A SMARCA2 ANKRD11 PACS2 EVC CHD2 SRCAP LMBRD1 HNRNPU | 5.03e-07 | 433 | 31 | 13 | HP:0000233 |
| HumanPheno | Radial deviation of finger | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 7.48e-07 | 448 | 31 | 13 | HP:0009466 |
| HumanPheno | Finger clinodactyly | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 8.29e-07 | 452 | 31 | 13 | HP:0040019 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 9.18e-07 | 456 | 31 | 13 | HP:0009485 |
| HumanPheno | Deviation of finger | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 5.91e-06 | 537 | 31 | 13 | HP:0004097 |
| HumanPheno | Deviation of the hand or of fingers of the hand | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 1.02e-05 | 564 | 31 | 13 | HP:0009484 |
| HumanPheno | Clinodactyly | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PACS2 EVC KDM6B SRCAP MECP2 | 1.24e-05 | 574 | 31 | 13 | HP:0030084 |
| HumanPheno | Abnormal lip morphology | XYLT2 KMT2C ABL1 HMGA2 TCF20 SCN1A SMARCA2 ANKRD11 PUS1 DYNC2I1 PACS2 EVC CHD2 KDM6B SRCAP MECP2 LMBRD1 LARP7 HNRNPU | 1.40e-05 | 1249 | 31 | 19 | HP:0000159 |
| HumanPheno | Autistic behavior | KMT2C KMT2B TCF20 STAG1 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD1 CHD2 KDM6B SRCAP MECP2 | 1.43e-05 | 678 | 31 | 14 | HP:0000729 |
| HumanPheno | Abnormal calvaria morphology | FANCE KMT2C ABL1 HMGA2 KMT2B TCF20 RNPC3 SCN1A SMARCA2 ANKRD11 DYNC2I1 PACS2 CHD1 CHD4 GNAS KDM6B SRCAP MECP2 HNRNPU | 1.49e-05 | 1254 | 31 | 19 | HP:0002683 |
| HumanPheno | Short stature | FANCE XYLT2 KMT2C ABL1 HMGA2 KMT2B STAG1 RNPC3 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS SRCAP MECP2 LMBRD1 LARP7 HNRNPU | 1.88e-05 | 1407 | 31 | 20 | HP:0004322 |
| HumanPheno | Disinhibition | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 2.16e-05 | 807 | 31 | 15 | HP:0000734 |
| HumanPheno | Inappropriate behavior | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 2.16e-05 | 807 | 31 | 15 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 2.16e-05 | 807 | 31 | 15 | HP:5200123 |
| HumanPheno | Social disinhibition | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 2.16e-05 | 807 | 31 | 15 | HP:5200029 |
| HumanPheno | Abnormality of mouth size | KMT2B STAG1 SCN1A SMARCA2 ANKRD11 PACS2 CHD2 KDM6B SRCAP MECP2 LARP7 | 2.18e-05 | 425 | 31 | 11 | HP:0011337 |
| HumanPheno | Abnormal midface morphology | XYLT2 KMT2C ABL1 KMT2B TCF20 SMARCA2 ANKRD11 CHD1 GNAS KDM6B SRCAP MECP2 LARP7 HNRNPU | 2.22e-05 | 704 | 31 | 14 | HP:0000309 |
| HumanPheno | Abnormal hair morphology | FANCE XYLT2 KMT2C ABL1 HMGA2 KMT2B STAG1 SCN1A SMARCA2 ANKRD11 PUS1 PACS2 EVC CHD1 CHD2 GNAS SRCAP MECP2 LARP7 HNRNPU | 2.29e-05 | 1424 | 31 | 20 | HP:0001595 |
| HumanPheno | Lack of peer relationships | 2.38e-05 | 10 | 31 | 3 | HP:0002332 | |
| HumanPheno | Abnormal peer relationships | 2.38e-05 | 10 | 31 | 3 | HP:5200016 | |
| HumanPheno | Diagnostic behavioral phenotype | KMT2C KMT2B TCF20 STAG1 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD1 CHD2 KDM6B SRCAP MECP2 | 4.40e-05 | 747 | 31 | 14 | HP:0025783 |
| HumanPheno | Abnormal curvature of the vertebral column | FANCE XYLT2 KMT2C ABL1 HMGA2 TCF20 STAG1 UBTF SCN1A SMARCA2 ANKRD11 PUS1 GNAS SRCAP MECP2 PRX LARP7 HNRNPU | 4.65e-05 | 1219 | 31 | 18 | HP:0010674 |
| HumanPheno | Abnormal facial shape | FANCE KMT2C HMGA2 KMT2B TCF20 STAG1 SCN1A SMARCA2 ANKRD11 PACS2 CHD2 CHD4 GNAS KDM6B SRCAP MECP2 LMBRD1 LARP7 | 4.76e-05 | 1221 | 31 | 18 | HP:0001999 |
| HumanPheno | Abnormal upper lip morphology | XYLT2 ABL1 TCF20 SCN1A SMARCA2 ANKRD11 PUS1 DYNC2I1 PACS2 EVC CHD2 SRCAP MECP2 LMBRD1 LARP7 HNRNPU | 5.08e-05 | 980 | 31 | 16 | HP:0000177 |
| HumanPheno | Hyperactivity | HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 KDM6B SRCAP MECP2 | 5.26e-05 | 558 | 31 | 12 | HP:0000752 |
| HumanPheno | Abnormally increased volition | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 5.34e-05 | 869 | 31 | 15 | HP:5200263 |
| HumanPheno | Abnormality of globe location or size | FANCE XYLT2 ABL1 HMGA2 KMT2B TCF20 STAG1 SCN1A SMARCA2 ANKRD11 PUS1 PACS2 EVC CHD2 CHD4 SRCAP LARP7 HNRNPU | 6.37e-05 | 1246 | 31 | 18 | HP:0000489 |
| HumanPheno | Abnormality of globe location | FANCE XYLT2 ABL1 HMGA2 KMT2B TCF20 STAG1 SCN1A SMARCA2 ANKRD11 PUS1 PACS2 EVC CHD4 SRCAP LARP7 HNRNPU | 6.61e-05 | 1122 | 31 | 17 | HP:0100886 |
| HumanPheno | Abnormal finger morphology | FANCE XYLT2 KMT2C ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD1 CHD4 GNAS KDM6B SRCAP MECP2 | 6.80e-05 | 1385 | 31 | 19 | HP:0001167 |
| HumanPheno | Abnormal testis morphology | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 7.19e-05 | 1129 | 31 | 17 | HP:0000035 |
| HumanPheno | Cryptorchidism | FANCE XYLT2 ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 KDM6B SRCAP MECP2 | 7.20e-05 | 780 | 31 | 14 | HP:0000028 |
| HumanPheno | Non-obstructive azoospermia | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 7.45e-05 | 1132 | 31 | 17 | HP:0011961 |
| HumanPheno | Abnormality of calvarial morphology | FANCE KMT2C ABL1 HMGA2 KMT2B TCF20 RNPC3 SCN1A SMARCA2 ANKRD11 DYNC2I1 PACS2 CHD1 CHD4 KDM6B MECP2 HNRNPU | 7.63e-05 | 1134 | 31 | 17 | HP:0002648 |
| HumanPheno | Abnormal eyelid morphology | FANCE KMT2C ABL1 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 PUS1 DYNC2I1 PACS2 CHD1 CHD4 KDM6B SRCAP MECP2 LMBRD1 LARP7 HNRNPU | 8.69e-05 | 1408 | 31 | 19 | HP:0000492 |
| HumanPheno | Abnormal social development | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 9.06e-05 | 908 | 31 | 15 | HP:0025732 |
| HumanPheno | Azoospermia | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 9.98e-05 | 1157 | 31 | 17 | HP:0000027 |
| HumanPheno | Abnormal relationship | 1.08e-04 | 16 | 31 | 3 | HP:5200024 | |
| HumanPheno | Syndactyly | FANCE HMGA2 KMT2B STAG1 SCN1A ANKRD11 DYNC2I1 CHD2 KDM6B MECP2 | 1.12e-04 | 417 | 31 | 10 | HP:0001159 |
| HumanPheno | Abnormal spermatogenesis | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 1.45e-04 | 1190 | 31 | 17 | HP:0008669 |
| HumanPheno | Abnormality of the forehead | FANCE ABL1 HMGA2 KMT2B TCF20 RNPC3 SCN1A SMARCA2 ANKRD11 DYNC2I1 PACS2 CHD1 CHD2 KDM6B SRCAP LARP7 HNRNPU | 1.77e-04 | 1208 | 31 | 17 | HP:0000290 |
| HumanPheno | Abnormal hand morphology | FANCE ABL1 HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC GNAS KDM6B SRCAP MECP2 PRX | 1.77e-04 | 1082 | 31 | 16 | HP:0005922 |
| HumanPheno | Frontal bossing | FANCE ABL1 HMGA2 KMT2B TCF20 RNPC3 SCN1A SMARCA2 ANKRD11 DYNC2I1 PACS2 CHD1 HNRNPU | 1.84e-04 | 738 | 31 | 13 | HP:0002007 |
| HumanPheno | Abnormal shape of the frontal region | FANCE ABL1 HMGA2 KMT2B TCF20 RNPC3 SCN1A SMARCA2 ANKRD11 DYNC2I1 PACS2 CHD1 HNRNPU | 1.91e-04 | 741 | 31 | 13 | HP:0011218 |
| HumanPheno | Abnormal frontal bone morphology | FANCE ABL1 HMGA2 KMT2B TCF20 RNPC3 SCN1A SMARCA2 ANKRD11 DYNC2I1 PACS2 CHD1 HNRNPU | 1.94e-04 | 742 | 31 | 13 | HP:0430000 |
| HumanPheno | Abnormal male internal genitalia morphology | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 2.57e-04 | 1243 | 31 | 17 | HP:0000022 |
| HumanPheno | Abnormality of upper lip vermillion | TCF20 SCN1A SMARCA2 ANKRD11 PACS2 CHD2 SRCAP MECP2 LMBRD1 HNRNPU | 2.73e-04 | 464 | 31 | 10 | HP:0011339 |
| HumanPheno | Scoliosis | FANCE KMT2C ABL1 HMGA2 TCF20 STAG1 SCN1A SMARCA2 ANKRD11 PUS1 GNAS SRCAP MECP2 PRX LARP7 HNRNPU | 2.78e-04 | 1122 | 31 | 16 | HP:0002650 |
| HumanPheno | Delayed speech and language development | KMT2C HMGA2 KMT2B TCF20 STAG1 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 HNRNPU | 2.81e-04 | 1123 | 31 | 16 | HP:0000750 |
| HumanPheno | Functional abnormality of male internal genitalia | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 3.35e-04 | 1269 | 31 | 17 | HP:0000025 |
| HumanPheno | Medial flaring of the eyebrow | 3.43e-04 | 228 | 31 | 7 | HP:0010747 | |
| HumanPheno | Abnormal cardiac septum morphology | FANCE XYLT2 ABL1 STAG1 ANKRD11 DYNC2I1 PACS2 EVC CHD4 SRCAP LMBRD1 LARP7 HNRNPU | 3.55e-04 | 787 | 31 | 13 | HP:0001671 |
| HumanPheno | Reduced impulse control | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 4.05e-04 | 1032 | 31 | 15 | HP:5200045 |
| HumanPheno | Abnormality of skeletal maturation | 4.82e-04 | 405 | 31 | 9 | HP:0000927 | |
| HumanPheno | Abnormal lower lip morphology | 4.94e-04 | 242 | 31 | 7 | HP:0000178 | |
| HumanPheno | Language impairment | KMT2C HMGA2 KMT2B TCF20 STAG1 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 HNRNPU | 5.02e-04 | 1178 | 31 | 16 | HP:0002463 |
| HumanPheno | Abnormal male reproductive system physiology | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 5.24e-04 | 1314 | 31 | 17 | HP:0012874 |
| HumanPheno | Status epilepticus without prominent motor symptoms | 5.41e-04 | 27 | 31 | 3 | HP:0031475 | |
| HumanPheno | Kyphosis | 5.88e-04 | 510 | 31 | 10 | HP:0002808 | |
| HumanPheno | Abnormal male external genitalia morphology | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 6.05e-04 | 1329 | 31 | 17 | HP:0000032 |
| HumanPheno | Epicanthus | FANCE KMT2B TCF20 SMARCA2 DYNC2I1 CHD4 KDM6B SRCAP MECP2 LMBRD1 HNRNPU | 6.21e-04 | 614 | 31 | 11 | HP:0000286 |
| HumanPheno | Abnormal palate morphology | FANCE KMT2C ABL1 HMGA2 KMT2B STAG1 SMARCA2 ANKRD11 PUS1 DYNC2I1 EVC CHD4 KDM6B MECP2 LMBRD1 HNRNPU | 6.38e-04 | 1202 | 31 | 16 | HP:0000174 |
| HumanPheno | Aggressive behavior | 6.46e-04 | 516 | 31 | 10 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 6.46e-04 | 516 | 31 | 10 | HP:0006919 | |
| HumanPheno | Abnormality of the outer ear | FANCE XYLT2 KMT2C HMGA2 KMT2B TCF20 STAG1 SMARCA2 ANKRD11 EVC CHD4 KDM6B SRCAP MECP2 LMBRD1 LARP7 HNRNPU | 6.52e-04 | 1337 | 31 | 17 | HP:0000356 |
| HumanPheno | Epileptic encephalopathy | 6.68e-04 | 119 | 31 | 5 | HP:0200134 | |
| HumanPheno | EEG with generalized slow activity | 6.70e-04 | 29 | 31 | 3 | HP:0010845 | |
| HumanPheno | Microcephaly | FANCE KMT2C HMGA2 KMT2B STAG1 UBTF RNPC3 SCN1A SMARCA2 ANKRD11 PUS1 PACS2 CHD2 SRCAP MECP2 LARP7 HNRNPU | 6.77e-04 | 1341 | 31 | 17 | HP:0000252 |
| HumanPheno | Thin upper lip vermilion | 7.20e-04 | 339 | 31 | 8 | HP:0000219 | |
| HumanPheno | Thin lips | 7.20e-04 | 339 | 31 | 8 | HP:0000213 | |
| HumanPheno | Decreased head circumference | FANCE KMT2C HMGA2 KMT2B STAG1 UBTF RNPC3 SCN1A SMARCA2 ANKRD11 PUS1 PACS2 CHD2 SRCAP MECP2 LARP7 HNRNPU | 7.64e-04 | 1354 | 31 | 17 | HP:0040195 |
| HumanPheno | Deeply set eye | 8.72e-04 | 266 | 31 | 7 | HP:0000490 | |
| HumanPheno | Speech apraxia | 8.98e-04 | 32 | 31 | 3 | HP:0011098 | |
| HumanPheno | Abnormal external genitalia | FANCE XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 DYNC2I1 PACS2 EVC CHD4 GNAS KDM6B SRCAP MECP2 LARP7 | 9.01e-04 | 1372 | 31 | 17 | HP:0000811 |
| HumanPheno | Synophrys | 9.63e-04 | 195 | 31 | 6 | HP:0000664 | |
| HumanPheno | Acetabular spurs | 9.81e-04 | 8 | 31 | 2 | HP:0010454 | |
| HumanPheno | Abnormal motivation | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LMBRD1 LARP7 | 1.14e-03 | 1263 | 31 | 16 | HP:5200275 |
| HumanPheno | Abnormal volitional state | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LMBRD1 LARP7 | 1.14e-03 | 1263 | 31 | 16 | HP:0025780 |
| HumanPheno | Thick vermilion border | 1.16e-03 | 279 | 31 | 7 | HP:0012471 | |
| HumanPheno | Motor stereotypy | 1.18e-03 | 280 | 31 | 7 | HP:0000733 | |
| HumanPheno | Abnormal cheek morphology | 1.23e-03 | 282 | 31 | 7 | HP:0004426 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 1.24e-03 | 368 | 31 | 8 | HP:0031432 | |
| HumanPheno | Impairment in personality functioning | KMT2C HMGA2 KMT2B TCF20 UBTF SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 1.24e-03 | 1141 | 31 | 15 | HP:0031466 |
| HumanPheno | Cafe-au-lait spot | 1.27e-03 | 137 | 31 | 5 | HP:0000957 | |
| HumanPheno | Facial hypertrichosis | 1.28e-03 | 206 | 31 | 6 | HP:0002219 | |
| HumanPheno | Intellectual disability, severe | 1.31e-03 | 371 | 31 | 8 | HP:0010864 | |
| HumanPheno | Status epilepticus | 1.31e-03 | 207 | 31 | 6 | HP:0002133 | |
| HumanPheno | Abnormality of the urethra | 1.32e-03 | 465 | 31 | 9 | HP:0000795 | |
| HumanPheno | Everted lower lip vermilion | 1.35e-03 | 139 | 31 | 5 | HP:0000232 | |
| HumanPheno | Abnormal eyebrow morphology | XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 PACS2 CHD1 LARP7 HNRNPU | 1.37e-03 | 674 | 31 | 11 | HP:0000534 |
| HumanPheno | Tonic seizure | 1.39e-03 | 140 | 31 | 5 | HP:0032792 | |
| HumanPheno | Abnormal hair pattern | XYLT2 HMGA2 STAG1 SCN1A SMARCA2 ANKRD11 PACS2 CHD2 GNAS SRCAP HNRNPU | 1.41e-03 | 676 | 31 | 11 | HP:0010720 |
| HumanPheno | Abnormal nasal bridge morphology | HMGA2 TCF20 STAG1 SCN1A SMARCA2 ANKRD11 DYNC2I1 PACS2 CHD2 GNAS KDM6B SRCAP MECP2 LARP7 | 1.44e-03 | 1029 | 31 | 14 | HP:0000422 |
| HumanPheno | Perseverative thought | 1.45e-03 | 377 | 31 | 8 | HP:0030223 | |
| HumanPheno | Abnormality of the dentition | XYLT2 KMT2C ABL1 HMGA2 STAG1 SMARCA2 ANKRD11 PACS2 EVC GNAS KDM6B SRCAP MECP2 LARP7 | 1.45e-03 | 1030 | 31 | 14 | HP:0000164 |
| Domain | AT_hook | 1.89e-09 | 27 | 84 | 6 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.89e-09 | 27 | 84 | 6 | IPR017956 | |
| Domain | HMGA | 8.78e-08 | 3 | 84 | 3 | IPR000116 | |
| Domain | SNF2_N | 2.99e-07 | 32 | 84 | 5 | IPR000330 | |
| Domain | SNF2_N | 2.99e-07 | 32 | 84 | 5 | PF00176 | |
| Domain | HMGI_Y | 3.50e-07 | 4 | 84 | 3 | PS00354 | |
| Domain | AT_hook | 6.65e-07 | 16 | 84 | 4 | PF02178 | |
| Domain | Helicase_C | 8.69e-06 | 107 | 84 | 6 | PF00271 | |
| Domain | HELICc | 8.69e-06 | 107 | 84 | 6 | SM00490 | |
| Domain | Helicase_C | 9.16e-06 | 108 | 84 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 9.66e-06 | 109 | 84 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 9.66e-06 | 109 | 84 | 6 | PS51192 | |
| Domain | DEXDc | 9.66e-06 | 109 | 84 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.02e-05 | 110 | 84 | 6 | IPR014001 | |
| Domain | HMGI/Y_DNA-bd_CS | 1.09e-05 | 31 | 84 | 4 | IPR000637 | |
| Domain | Chromodomain-like | 1.24e-05 | 32 | 84 | 4 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.41e-05 | 33 | 84 | 4 | IPR000953 | |
| Domain | CHROMO | 1.41e-05 | 33 | 84 | 4 | SM00298 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.79e-05 | 35 | 84 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 2.50e-05 | 38 | 84 | 4 | PS00690 | |
| Domain | NPIP | 3.08e-05 | 14 | 84 | 3 | IPR009443 | |
| Domain | SOHO | 5.98e-05 | 3 | 84 | 2 | PS50831 | |
| Domain | Sorb | 5.98e-05 | 3 | 84 | 2 | SM00459 | |
| Domain | DUF4208 | 5.98e-05 | 3 | 84 | 2 | PF13907 | |
| Domain | Sorb | 5.98e-05 | 3 | 84 | 2 | PF02208 | |
| Domain | DUF4208 | 5.98e-05 | 3 | 84 | 2 | SM01176 | |
| Domain | DUF4208 | 5.98e-05 | 3 | 84 | 2 | IPR025260 | |
| Domain | SoHo_dom | 5.98e-05 | 3 | 84 | 2 | IPR003127 | |
| Domain | HSA | 1.19e-04 | 4 | 84 | 2 | SM00573 | |
| Domain | HSA | 1.19e-04 | 4 | 84 | 2 | PS51204 | |
| Domain | HSA_dom | 1.19e-04 | 4 | 84 | 2 | IPR014012 | |
| Domain | HSA | 1.19e-04 | 4 | 84 | 2 | PF07529 | |
| Domain | EPHD | 1.27e-04 | 22 | 84 | 3 | PS51805 | |
| Domain | Chromo_domain | 1.66e-04 | 24 | 84 | 3 | IPR023780 | |
| Domain | FYrich_C | 1.98e-04 | 5 | 84 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.98e-04 | 5 | 84 | 2 | IPR003888 | |
| Domain | FYRC | 1.98e-04 | 5 | 84 | 2 | SM00542 | |
| Domain | FYRN | 1.98e-04 | 5 | 84 | 2 | SM00541 | |
| Domain | FYRN | 1.98e-04 | 5 | 84 | 2 | PF05964 | |
| Domain | FYRC | 1.98e-04 | 5 | 84 | 2 | PF05965 | |
| Domain | FYRC | 1.98e-04 | 5 | 84 | 2 | PS51543 | |
| Domain | FYRN | 1.98e-04 | 5 | 84 | 2 | PS51542 | |
| Domain | Chromo | 2.12e-04 | 26 | 84 | 3 | PF00385 | |
| Domain | CHROMO_1 | 2.65e-04 | 28 | 84 | 3 | PS00598 | |
| Domain | CHROMO_2 | 2.65e-04 | 28 | 84 | 3 | PS50013 | |
| Domain | PHD | 6.95e-04 | 89 | 84 | 4 | SM00249 | |
| Domain | TCEAL1 | 7.05e-04 | 9 | 84 | 2 | IPR010370 | |
| Domain | Znf_PHD | 7.56e-04 | 91 | 84 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 8.88e-04 | 95 | 84 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 9.23e-04 | 96 | 84 | 4 | PS01359 | |
| Domain | TF_A-like/BEX | 1.76e-03 | 14 | 84 | 2 | IPR021156 | |
| Domain | BEX | 1.76e-03 | 14 | 84 | 2 | PF04538 | |
| Domain | Post-SET_dom | 2.30e-03 | 16 | 84 | 2 | IPR003616 | |
| Domain | PostSET | 2.30e-03 | 16 | 84 | 2 | SM00508 | |
| Domain | POST_SET | 2.30e-03 | 16 | 84 | 2 | PS50868 | |
| Domain | Chromodomain_CS | 2.92e-03 | 18 | 84 | 2 | IPR023779 | |
| Domain | HMG_box_dom | 3.14e-03 | 65 | 84 | 3 | IPR009071 | |
| Domain | Znf_FYVE_PHD | 4.37e-03 | 147 | 84 | 4 | IPR011011 | |
| Pathway | WP_RETT_SYNDROME | 1.48e-06 | 48 | 58 | 5 | M39759 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.45e-04 | 65 | 58 | 4 | M39682 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 1.61e-04 | 26 | 58 | 3 | M47439 | |
| Pathway | REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION | 1.65e-04 | 5 | 58 | 2 | M27770 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SCAF1 H1-10 KMT2C PAXBP1 KMT2B TCF20 ARID4A INTS13 CTR9 UBTF ZNF644 ANKRD11 MLLT1 CHD2 CHD4 HMGA1 SRCAP NOP2 MECP2 HNRNPU DHX8 MYBL2 FTSJ3 | 1.60e-13 | 1294 | 90 | 23 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SCAF1 H1-10 SORBS2 PAXBP1 KMT2B TCF20 ARID4A CTR9 ZNF644 SMARCA2 PACS2 AFF1 CHD4 HMGA1 NOP2 MECP2 REXO1 MYBL2 | 1.25e-12 | 774 | 90 | 18 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H1-10 CYFIP1 PAXBP1 TCF20 ARID4A PRRC2C UBTF ZNF644 NOC3L ANKRD11 MLLT1 CHD1 CHD4 HMGA1 NOP2 MECP2 HNRNPU MYBL2 FTSJ3 | 4.08e-12 | 954 | 90 | 19 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KMT2B TCF20 STAG1 ARID4A UBTF ZNF644 CHD1 CHD2 CHD4 SRCAP NOP2 MECP2 DHX8 HDGF MYBL2 | 5.02e-11 | 608 | 90 | 15 | 36089195 |
| Pubmed | H1-10 TCF20 PRRC2C UBTF UBR4 NOC3L SMARCA2 CHD1 CHD2 CHD4 NOP2 ZCCHC3 LARP7 DHX8 FTSJ3 | 1.35e-10 | 653 | 90 | 15 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SCAF1 H1-10 NAMPT CYFIP1 PAXBP1 CTR9 UBTF NT5DC2 UBR4 NOC3L PUS1 CHD1 CHD4 GNAS NOP2 LARP7 HNRNPU DHX8 HDGF FTSJ3 | 5.14e-10 | 1425 | 90 | 20 | 30948266 |
| Pubmed | SCAF1 KMT2C CYFIP1 PAXBP1 KMT2B NUMBL INTS13 CTR9 NOC3L SMARCA2 ANKRD11 MLLT1 CHD1 CHD2 ALKBH5 PDLIM2 MECP2 CEP170B LARP7 DHX8 | 1.20e-09 | 1497 | 90 | 20 | 31527615 | |
| Pubmed | KMT2C TNRC18 KMT2B TCF20 CTR9 PRRC2C UBTF ZNF644 SMARCA2 CHD4 HMGA1 NOP2 ALKBH5 MECP2 HNRNPU HDGF MYBL2 | 3.11e-09 | 1103 | 90 | 17 | 34189442 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SCAF1 H1-10 NAMPT PAXBP1 CTR9 NT5DC2 UBR4 NOC3L SMARCA2 PUS1 CHD1 CHD2 CHD4 NOP2 ZCCHC3 LARP7 HNRNPU FTSJ3 | 6.61e-09 | 1318 | 90 | 18 | 30463901 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | H1-10 NAMPT CYFIP1 HMGA2 TCF20 CTR9 UBTF UBR4 NOC3L SMARCA2 CHD1 CHD2 CHD4 HMGA1 SRCAP NOP2 HNRNPU FTSJ3 | 9.90e-09 | 1353 | 90 | 18 | 29467282 |
| Pubmed | 1.95e-08 | 251 | 90 | 9 | 31076518 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.06e-08 | 341 | 90 | 10 | 32971831 | |
| Pubmed | KIF13B TNRC18 HMGA2 STAG1 CTR9 PRRC2C UBR4 NOC3L MLLT1 CHD2 CHD4 HMGA1 SRCAP JSRP1 MECP2 PRX LARP7 HNRNPU | 2.62e-08 | 1442 | 90 | 18 | 35575683 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF13B CYFIP1 CTR9 PRRC2C ZNF644 E2F7 SORBS1 GNAS SRCAP ALKBH5 CEP170B MYBL2 | 4.03e-08 | 588 | 90 | 12 | 38580884 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | H1-10 PAXBP1 CTR9 PRRC2C UBTF NOC3L SMARCA2 CHD4 NOP2 LARP7 HNRNPU FTSJ3 | 5.49e-08 | 605 | 90 | 12 | 28977666 |
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 9326634 | ||
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 7.22e-08 | 41 | 90 | 5 | 20431927 | |
| Pubmed | 8.99e-08 | 300 | 90 | 9 | 28561026 | ||
| Pubmed | 1.20e-07 | 222 | 90 | 8 | 37071664 | ||
| Pubmed | H1-10 KMT2C KMT2B TCF20 ARID4A PRRC2C UBTF ZNF644 UBR4 NOC3L SMARCA2 MLLT1 SRCAP NOP2 ZCCHC3 MYBL2 FTSJ3 | 1.34e-07 | 1429 | 90 | 17 | 35140242 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | H1-10 PRRC2C UBTF NOC3L PUS1 CHD2 NOP2 ALKBH5 ZCCHC3 LARP7 HNRNPU DHX8 FTSJ3 | 1.63e-07 | 807 | 90 | 13 | 22681889 |
| Pubmed | SCAF1 H1-10 INTS13 NT5DC2 FAT3 SMARCA2 MLLT1 C16orf96 CHD4 SRCAP PDLIM2 MECP2 CEP170B LARP7 FTSJ3 | 1.73e-07 | 1116 | 90 | 15 | 31753913 | |
| Pubmed | 1.82e-07 | 157 | 90 | 7 | 30186101 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 2.01e-07 | 330 | 90 | 9 | 33301849 | |
| Pubmed | H1-10 CYFIP1 PAXBP1 KMT2B UBTF NOC3L CHD1 CHD4 NOP2 LARP7 HNRNPU DHX8 FTSJ3 | 2.83e-07 | 847 | 90 | 13 | 35850772 | |
| Pubmed | 2.96e-07 | 103 | 90 | 6 | 32744500 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 3.22e-07 | 349 | 90 | 9 | 25665578 | |
| Pubmed | NAMPT TCF20 INTS13 CTR9 UBTF TCEAL4 UBR4 SMARCA2 CHD1 CHD2 CHD4 HMGA1 LARP7 HDGF | 3.39e-07 | 1014 | 90 | 14 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SCAF1 H1-10 HMGA2 TCF20 UBTF CHD1 CHD4 HMGA1 GNAS SRCAP NOP2 HNRNPU DHX8 FTSJ3 | 3.81e-07 | 1024 | 90 | 14 | 24711643 |
| Pubmed | 3.95e-07 | 469 | 90 | 10 | 27634302 | ||
| Pubmed | 4.18e-07 | 472 | 90 | 10 | 38943005 | ||
| Pubmed | 5.62e-07 | 272 | 90 | 8 | 31010829 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | H1-10 PRRC2C UBTF RNPC3 NOC3L CHD4 NOP2 ZCCHC3 LARP7 HNRNPU DHX8 FTSJ3 | 6.19e-07 | 759 | 90 | 12 | 35915203 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 8.87e-07 | 289 | 90 | 8 | 23752268 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SCAF1 KMT2C TNRC18 ABL1 KMT2B CASKIN1 UBR4 ANKRD11 MLLT1 KDM6B SRCAP REXO1 CEP170B MYBL2 | 9.40e-07 | 1105 | 90 | 14 | 35748872 |
| Pubmed | KIF13B SORBS2 CYFIP1 TCF20 NUMBL PRRC2C CASKIN1 UBR4 SORBS1 CHD4 NOP2 CEP170B HNRNPU | 1.19e-06 | 963 | 90 | 13 | 28671696 | |
| Pubmed | 1.27e-06 | 72 | 90 | 5 | 31248990 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | ABL1 NOC3L MLLT1 AFF1 CHD2 FAM90A1 NOP2 LARP7 MKNK1 DHX8 FTSJ3 | 1.87e-06 | 695 | 90 | 11 | 23602568 |
| Pubmed | 2.23e-06 | 228 | 90 | 7 | 30471916 | ||
| Pubmed | 2.72e-06 | 11 | 90 | 3 | 24367103 | ||
| Pubmed | 2.72e-06 | 11 | 90 | 3 | 20471949 | ||
| Pubmed | H1-10 PAXBP1 CTR9 PRRC2C NOC3L CHD4 HMGA1 NOP2 ZCCHC3 HNRNPU FTSJ3 | 3.03e-06 | 731 | 90 | 11 | 29298432 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | H1-10 NAMPT CYFIP1 PAXBP1 CTR9 PRRC2C UBR4 CHD1 CHD4 HMGA1 NOP2 HNRNPU DHX8 HDGF FTSJ3 | 3.35e-06 | 1415 | 90 | 15 | 28515276 |
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 3.77e-06 | 159 | 90 | 6 | 34578187 | |
| Pubmed | H1-10 TNRC18 CYFIP1 PAXBP1 SMARCA2 MLLT1 AFF1 CHD4 GNAS LARP7 HNRNPU DHX8 HDGF FTSJ3 | 3.84e-06 | 1247 | 90 | 14 | 27684187 | |
| Pubmed | 4.21e-06 | 251 | 90 | 7 | 28077445 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SORBS2 PAXBP1 HMGA2 TCF20 NUMBL RNPC3 CHD2 CHD4 HMGA1 SRCAP MECP2 HNRNPU DHX8 | 4.26e-06 | 1082 | 90 | 13 | 38697112 |
| Pubmed | H1-10 CYFIP1 PRRC2C UBTF SMARCA2 GNAS NOP2 LARP7 HNRNPU FTSJ3 | 4.47e-06 | 615 | 90 | 10 | 31048545 | |
| Pubmed | 4.66e-06 | 483 | 90 | 9 | 36912080 | ||
| Pubmed | 4.70e-06 | 13 | 90 | 3 | 21502505 | ||
| Pubmed | 4.79e-06 | 43 | 90 | 4 | 26030138 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NAMPT NUMBL PRRC2C UBTF NOC3L CHD1 CHD4 HMGA1 SRCAP NOP2 HNRNPU FTSJ3 | 5.26e-06 | 934 | 90 | 12 | 33916271 |
| Pubmed | H1-10 PAXBP1 NUMBL CTR9 UBTF NT5DC2 ZNF644 UBR4 NOC3L ANKRD11 CHD1 GNAS NOP2 LARP7 FTSJ3 | 6.09e-06 | 1487 | 90 | 15 | 33957083 | |
| Pubmed | 6.46e-06 | 268 | 90 | 7 | 33640491 | ||
| Pubmed | HMGA regulates the global chromatin state and neurogenic potential in neocortical precursor cells. | 6.62e-06 | 2 | 90 | 2 | 22797695 | |
| Pubmed | Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation. | 6.62e-06 | 2 | 90 | 2 | 14571323 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20004941 | ||
| Pubmed | Expression of high mobility group A proteins in oral leukoplakia. | 6.62e-06 | 2 | 90 | 2 | 24122990 | |
| Pubmed | Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors. | 6.62e-06 | 2 | 90 | 2 | 30999005 | |
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 6.62e-06 | 2 | 90 | 2 | 25297984 | |
| Pubmed | HMGA gene rearrangement is a recurrent somatic alteration in polypoid endometriosis. | 6.62e-06 | 2 | 90 | 2 | 22221703 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 26657872 | ||
| Pubmed | HMGI/Y proteins: flexible regulators of transcription and chromatin structure. | 6.62e-06 | 2 | 90 | 2 | 11406267 | |
| Pubmed | Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays. | 6.62e-06 | 2 | 90 | 2 | 33139812 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17935122 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20093853 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23530587 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21782149 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17654722 | ||
| Pubmed | HMGA1 and HMGA2 protein expression in mouse spermatogenesis. | 6.62e-06 | 2 | 90 | 2 | 12032866 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18202751 | ||
| Pubmed | Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells. | 6.62e-06 | 2 | 90 | 2 | 25557289 | |
| Pubmed | Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype. | 6.62e-06 | 2 | 90 | 2 | 24728959 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17005673 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19609535 | ||
| Pubmed | 6.77e-06 | 506 | 90 | 9 | 30890647 | ||
| Pubmed | 7.75e-06 | 655 | 90 | 10 | 35819319 | ||
| Pubmed | XYLT2 SCAF1 H1-10 KMT2C NAMPT ARID4A CTR9 UBTF UBR4 ANKRD11 E2F7 UBA3 CHD1 NOP2 | 7.79e-06 | 1327 | 90 | 14 | 32694731 | |
| Pubmed | H1-10 CTR9 UBTF SCN1A E2F7 AFF1 CHD1 CHD2 CHD4 ZCCHC3 LARP7 HNRNPU FTSJ3 | 8.43e-06 | 1153 | 90 | 13 | 29845934 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | FANCE PAXBP1 STAG1 ZNF644 SMARCA2 DYNC2I1 HMGA1 GNAS NOP2 CEP170B LARP7 HNRNPU MYBL2 | 8.59e-06 | 1155 | 90 | 13 | 20360068 |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 9.26e-06 | 186 | 90 | 6 | 33637726 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.38e-06 | 398 | 90 | 8 | 35016035 | |
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 1.08e-05 | 191 | 90 | 6 | 21907836 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.28e-05 | 197 | 90 | 6 | 20811636 | |
| Pubmed | 1.31e-05 | 417 | 90 | 8 | 36537216 | ||
| Pubmed | 1.33e-05 | 551 | 90 | 9 | 34728620 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HMGA2 STAG1 ARID4A PRRC2C ZNF644 UBR4 CHD4 HMGA1 MECP2 LARP7 MYBL2 | 1.35e-05 | 857 | 90 | 11 | 25609649 |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 1.39e-05 | 56 | 90 | 4 | 26919559 | |
| Pubmed | Lost in transcription: molecular mechanisms that control HIV latency. | 1.58e-05 | 19 | 90 | 3 | 23518577 | |
| Pubmed | H1-10 PAXBP1 PRRC2C RNPC3 NOP2 ZCCHC3 LARP7 HNRNPU DHX8 FTSJ3 | 1.61e-05 | 713 | 90 | 10 | 29802200 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.64e-05 | 430 | 90 | 8 | 38172120 | |
| Pubmed | 1.82e-05 | 723 | 90 | 10 | 34133714 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.93e-05 | 440 | 90 | 8 | 34244565 | |
| Pubmed | 1.95e-05 | 61 | 90 | 4 | 20305087 | ||
| Pubmed | 1.96e-05 | 441 | 90 | 8 | 31239290 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 10889043 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 33835503 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11801530 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 32005694 | ||
| Pubmed | Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. | 1.98e-05 | 3 | 90 | 2 | 7651535 | |
| Interaction | H3C1 interactions | H1-10 KMT2C TNRC18 HMGA2 KMT2B STAG1 CTR9 PRRC2C UBTF ZNF644 UBR4 NOC3L SMARCA2 PUS1 MLLT1 CHD1 CHD4 HMGA1 KDM6B SRCAP NOP2 MECP2 LARP7 HNRNPU HDGF FTSJ3 | 4.36e-15 | 901 | 87 | 26 | int:H3C1 |
| Interaction | CENPA interactions | H1-10 KMT2B TCF20 UBTF ZNF644 NOC3L SMARCA2 ANKRD11 MLLT1 CHD1 HMGA1 NOP2 MECP2 HNRNPU FTSJ3 | 7.06e-11 | 377 | 87 | 15 | int:CENPA |
| Interaction | ZNF330 interactions | H1-10 KMT2B TCF20 CTR9 UBTF ZNF644 NOC3L ANKRD11 MLLT1 CHD1 HMGA1 NOP2 ALKBH5 MECP2 LARP7 FTSJ3 | 7.12e-11 | 446 | 87 | 16 | int:ZNF330 |
| Interaction | NUP43 interactions | SCAF1 H1-10 PAXBP1 KMT2B TCF20 ARID4A PRRC2C UBTF ZNF644 NOC3L ANKRD11 CHD1 SRCAP MECP2 LARP7 DHX8 MYBL2 FTSJ3 | 1.45e-10 | 625 | 87 | 18 | int:NUP43 |
| Interaction | DDX23 interactions | SCAF1 PAXBP1 CTR9 UBTF NOC3L ANKRD11 MLLT1 CHD1 CHD2 CHD4 NOP2 MECP2 LARP7 HNRNPU DHX8 FTSJ3 | 2.10e-10 | 480 | 87 | 16 | int:DDX23 |
| Interaction | POLR1G interactions | KMT2B TCF20 CTR9 UBTF ZNF644 UBR4 NOC3L ANKRD11 MLLT1 CHD1 CHD2 SRCAP NOP2 MECP2 LARP7 FTSJ3 | 2.75e-10 | 489 | 87 | 16 | int:POLR1G |
| Interaction | H2BC8 interactions | HMGA2 KMT2B TCF20 STAG1 ARID4A UBTF ZNF644 CHD1 CHD4 HMGA1 SRCAP ALKBH5 MECP2 DHX8 HDGF MYBL2 | 2.92e-09 | 576 | 87 | 16 | int:H2BC8 |
| Interaction | H3-3A interactions | KMT2C KMT2B TCF20 STAG1 UBTF ZNF644 DYNC2I1 CHD1 CHD2 CHD4 HMGA1 KDM6B SRCAP MECP2 DHX8 HDGF MYBL2 | 1.78e-08 | 749 | 87 | 17 | int:H3-3A |
| Interaction | H1-4 interactions | SCAF1 TNRC18 HMGA2 CTR9 UBTF NOC3L CHD4 HMGA1 NOP2 PRX ZCCHC3 LARP7 DHX8 HDGF MYBL2 FTSJ3 | 1.83e-08 | 656 | 87 | 16 | int:H1-4 |
| Interaction | SSRP1 interactions | SCAF1 HMGA2 INTS13 CTR9 ZNF644 ANKRD11 CHD1 CHD2 CHD4 KDM6B NOP2 MECP2 REXO1 LARP7 HNRNPU HDGF | 3.34e-08 | 685 | 87 | 16 | int:SSRP1 |
| Interaction | SMC5 interactions | H1-10 CYFIP1 PAXBP1 TCF20 ARID4A PRRC2C UBTF ZNF644 NOC3L ANKRD11 MLLT1 CHD1 CHD4 HMGA1 NOP2 MECP2 HNRNPU MYBL2 FTSJ3 | 3.94e-08 | 1000 | 87 | 19 | int:SMC5 |
| Interaction | H2BC21 interactions | H1-10 KMT2B TCF20 ARID4A CTR9 ZNF644 MLLT1 CHD4 HMGA1 KDM6B SRCAP NOP2 MECP2 LARP7 HNRNPU HDGF | 4.17e-08 | 696 | 87 | 16 | int:H2BC21 |
| Interaction | CEBPA interactions | KMT2C TNRC18 KMT2B TCF20 STAG1 INTS13 CTR9 PRRC2C UBTF ZNF644 SMARCA2 CHD1 CHD4 HMGA1 NOP2 ALKBH5 MECP2 HNRNPU HDGF MYBL2 FTSJ3 | 5.12e-08 | 1245 | 87 | 21 | int:CEBPA |
| Interaction | MEN1 interactions | KIF13B H1-10 KMT2C CYFIP1 PAXBP1 KMT2B TCF20 STAG1 UBTF ZNF644 UBR4 NOC3L PUS1 CHD1 CHD4 SRCAP NOP2 DHX8 FTSJ3 | 6.18e-08 | 1029 | 87 | 19 | int:MEN1 |
| Interaction | CHD4 interactions | H1-10 PAXBP1 TCF20 CTR9 PRRC2C UBTF ZNF644 NOC3L SMARCA2 CHD4 HMGA1 NOP2 MECP2 LARP7 HNRNPU DHX8 MYBL2 FTSJ3 | 8.24e-08 | 938 | 87 | 18 | int:CHD4 |
| Interaction | DHX40 interactions | 1.20e-07 | 249 | 87 | 10 | int:DHX40 | |
| Interaction | H3C3 interactions | KMT2B TCF20 STAG1 ARID4A UBTF ZNF644 CHD1 CHD4 SRCAP NOP2 MECP2 DHX8 HDGF | 1.98e-07 | 495 | 87 | 13 | int:H3C3 |
| Interaction | SRPK2 interactions | SCAF1 PAXBP1 ABL1 PRRC2C UBTF RNPC3 UBR4 NOC3L CHD2 HMGA1 FAM90A1 NOP2 LARP7 DHX8 FTSJ3 | 3.90e-07 | 717 | 87 | 15 | int:SRPK2 |
| Interaction | PYHIN1 interactions | XYLT2 SCAF1 H1-10 TCF20 CTR9 UBTF CHD1 CHD4 MECP2 ZCCHC3 LARP7 | 4.00e-07 | 358 | 87 | 11 | int:PYHIN1 |
| Interaction | DHX8 interactions | 5.23e-07 | 292 | 87 | 10 | int:DHX8 | |
| Interaction | H4C6 interactions | 5.24e-07 | 69 | 87 | 6 | int:H4C6 | |
| Interaction | SNRNP40 interactions | SCAF1 PAXBP1 KMT2B TCF20 UBTF RNPC3 ZNF644 NOC3L CHD1 MECP2 LARP7 DHX8 MYBL2 FTSJ3 | 5.55e-07 | 637 | 87 | 14 | int:SNRNP40 |
| Interaction | PARP1 interactions | SCAF1 ABL1 HMGA2 STAG1 CTR9 UBTF ZNF644 NOC3L SMARCA2 MLLT1 CHD1 CHD4 HMGA1 SRCAP NOP2 MECP2 LARP7 HDGF MYBL2 FTSJ3 | 6.05e-07 | 1316 | 87 | 20 | int:PARP1 |
| Interaction | SIRT7 interactions | H1-10 TCF20 PRRC2C UBTF UBR4 NOC3L SMARCA2 CHD1 CHD2 CHD4 NOP2 ZCCHC3 LARP7 DHX8 FTSJ3 | 6.22e-07 | 744 | 87 | 15 | int:SIRT7 |
| Interaction | SUZ12 interactions | H1-10 SORBS2 PAXBP1 HMGA2 UBTF SMARCA2 UBA3 CHD1 CHD2 CHD4 HMGA1 NOP2 ZCCHC3 MYBL2 | 6.32e-07 | 644 | 87 | 14 | int:SUZ12 |
| Interaction | CIT interactions | SCAF1 H1-10 SORBS2 PAXBP1 TCF20 STAG1 CTR9 PRRC2C UBTF UBR4 NOC3L SMARCA2 CHD1 CHD2 CHD4 HMGA1 GNAS NOP2 HNRNPU DHX8 FTSJ3 | 6.55e-07 | 1450 | 87 | 21 | int:CIT |
| Interaction | CBX3 interactions | HMGA2 KMT2B TCF20 UBTF ZNF644 CHD1 CHD4 HMGA1 KDM6B MECP2 HNRNPU DHX8 HDGF MYBL2 | 6.56e-07 | 646 | 87 | 14 | int:CBX3 |
| Interaction | COIL interactions | NAMPT TCF20 CTR9 UBTF ZNF644 ANKRD11 MLLT1 CHD1 CHD4 MECP2 LARP7 DHX8 MYBL2 | 6.80e-07 | 552 | 87 | 13 | int:COIL |
| Interaction | TERF2IP interactions | PAXBP1 KMT2B TCF20 UBTF ZNF644 ANKRD11 CHD1 SRCAP PRX LARP7 HNRNPU DHX8 MYBL2 | 6.80e-07 | 552 | 87 | 13 | int:TERF2IP |
| Interaction | H1-5 interactions | SCAF1 H1-10 HMGA2 MLLT1 HMGA1 NOP2 ZCCHC3 LARP7 HNRNPU DHX8 MYBL2 FTSJ3 | 6.99e-07 | 463 | 87 | 12 | int:H1-5 |
| Interaction | H1-2 interactions | SCAF1 H1-10 HMGA2 CTR9 NOC3L CHD4 HMGA1 KDM6B NOP2 SLCO6A1 ZCCHC3 LARP7 HDGF FTSJ3 | 9.42e-07 | 666 | 87 | 14 | int:H1-2 |
| Interaction | NOP56 interactions | H1-10 UBTF NOC3L SMARCA2 ANKRD11 MLLT1 CHD1 CHD4 NOP2 MECP2 LARP7 HNRNPU FTSJ3 | 9.74e-07 | 570 | 87 | 13 | int:NOP56 |
| Interaction | MYCN interactions | SCAF1 H1-10 PAXBP1 TCF20 STAG1 PRRC2C UBTF NOC3L SMARCA2 PUS1 CHD2 CHD4 HMGA1 NOP2 MECP2 ZCCHC3 LARP7 HNRNPU HDGF FTSJ3 | 1.18e-06 | 1373 | 87 | 20 | int:MYCN |
| Interaction | CHD1 interactions | 1.29e-06 | 127 | 87 | 7 | int:CHD1 | |
| Interaction | APEX1 interactions | HMGA2 KMT2B TCF20 ARID4A INTS13 UBTF ZNF644 NOC3L ANKRD11 E2F7 CHD4 HMGA1 SRCAP NPIPB5 NOP2 MECP2 HNRNPU HDGF FTSJ3 | 1.57e-06 | 1271 | 87 | 19 | int:APEX1 |
| Interaction | DOT1L interactions | H1-10 CYFIP1 PAXBP1 UBTF NOC3L MLLT1 AFF1 CHD1 CHD4 HMGA1 NOP2 LARP7 HNRNPU DHX8 FTSJ3 | 1.71e-06 | 807 | 87 | 15 | int:DOT1L |
| Interaction | HMGA1 interactions | H1-10 TNRC18 HMGA2 TCF20 CTR9 ZNF644 CHD1 CHD4 HMGA1 SRCAP MECP2 | 1.87e-06 | 419 | 87 | 11 | int:HMGA1 |
| Interaction | FBL interactions | PRRC2C UBTF ZNF644 NOC3L CHD1 CHD4 NOP2 MECP2 ZCCHC3 LARP7 HNRNPU HDGF FTSJ3 | 3.44e-06 | 639 | 87 | 13 | int:FBL |
| Interaction | H3-4 interactions | H1-10 KMT2C PRRC2C MLLT1 AFF1 CHD1 CHD4 HMGA1 NOP2 REXO1 HNRNPU | 3.55e-06 | 448 | 87 | 11 | int:H3-4 |
| Interaction | PAF1 interactions | 4.04e-06 | 214 | 87 | 8 | int:PAF1 | |
| Interaction | HECTD1 interactions | H1-10 PAXBP1 PRRC2C UBTF NT5DC2 RNPC3 TCEAL4 NOC3L ANKRD11 CHD4 NOP2 ZCCHC3 LARP7 HNRNPU DHX8 FTSJ3 | 4.18e-06 | 984 | 87 | 16 | int:HECTD1 |
| Interaction | HDAC1 interactions | XYLT2 TNRC18 KMT2B TCF20 STAG1 ARID4A UBTF UBR4 SMARCA2 AFF1 CHD1 CHD4 MECP2 LARP7 HNRNPU HDGF FTSJ3 | 4.35e-06 | 1108 | 87 | 17 | int:HDAC1 |
| Interaction | LYAR interactions | 4.72e-06 | 373 | 87 | 10 | int:LYAR | |
| Interaction | MYBBP1A interactions | H1-10 UBTF NOC3L SMARCA2 CHD4 NOP2 MECP2 LARP7 HNRNPU HDGF FTSJ3 | 4.86e-06 | 463 | 87 | 11 | int:MYBBP1A |
| Interaction | BRIX1 interactions | 5.91e-06 | 300 | 87 | 9 | int:BRIX1 | |
| Interaction | KMT2A interactions | 8.53e-06 | 314 | 87 | 9 | int:KMT2A | |
| Interaction | TOP1 interactions | SCAF1 H1-10 HMGA2 TCF20 CTR9 CHD4 SRCAP NOP2 MECP2 LARP7 HNRNPU DHX8 HDGF | 8.65e-06 | 696 | 87 | 13 | int:TOP1 |
| Interaction | RPL10 interactions | SCAF1 H1-10 PRRC2C UBTF NOC3L CHD1 CHD4 NOP2 MECP2 LARP7 HNRNPU HDGF FTSJ3 | 9.48e-06 | 702 | 87 | 13 | int:RPL10 |
| Interaction | KPNA6 interactions | 1.04e-05 | 174 | 87 | 7 | int:KPNA6 | |
| Interaction | H2BC12 interactions | 1.04e-05 | 322 | 87 | 9 | int:H2BC12 | |
| Interaction | CHAF1A interactions | 1.04e-05 | 322 | 87 | 9 | int:CHAF1A | |
| Interaction | SRSF6 interactions | SCAF1 PAXBP1 RNPC3 NOC3L CHD4 NOP2 MECP2 ZCCHC3 LARP7 DHX8 FTSJ3 | 1.06e-05 | 503 | 87 | 11 | int:SRSF6 |
| Interaction | H2BC1 interactions | 1.20e-05 | 178 | 87 | 7 | int:H2BC1 | |
| Interaction | DDX21 interactions | H1-10 CTR9 PRRC2C SURF2 NOC3L CHD2 CHD4 NOP2 MECP2 LARP7 HNRNPU HDGF FTSJ3 | 1.21e-05 | 718 | 87 | 13 | int:DDX21 |
| Interaction | CGAS interactions | 1.24e-05 | 329 | 87 | 9 | int:CGAS | |
| Interaction | NPM1 interactions | SCAF1 H1-10 CYFIP1 HMGA2 PRRC2C CASKIN1 NOC3L AFF1 CHD1 CHD4 HMGA1 FAM90A1 NOP2 MECP2 LARP7 HNRNPU FTSJ3 | 1.26e-05 | 1201 | 87 | 17 | int:NPM1 |
| Interaction | LHX2 interactions | 1.44e-05 | 183 | 87 | 7 | int:LHX2 | |
| Interaction | RNF151 interactions | 1.54e-05 | 123 | 87 | 6 | int:RNF151 | |
| Interaction | PES1 interactions | 1.58e-05 | 258 | 87 | 8 | int:PES1 | |
| Interaction | SIRT6 interactions | CTR9 UBTF ZNF644 FAT3 NOC3L SMARCA2 DYNC2I1 CHD4 SRCAP NOP2 LARP7 FTSJ3 | 1.59e-05 | 628 | 87 | 12 | int:SIRT6 |
| Interaction | H2BC4 interactions | 1.63e-05 | 259 | 87 | 8 | int:H2BC4 | |
| Interaction | NIFK interactions | 1.66e-05 | 431 | 87 | 10 | int:NIFK | |
| Interaction | REXO4 interactions | 1.72e-05 | 261 | 87 | 8 | int:REXO4 | |
| Interaction | HDAC2 interactions | SORBS2 TCF20 STAG1 ARID4A PRRC2C ZNF644 SMARCA2 CHD4 HMGA1 MECP2 LARP7 HNRNPU HDGF MYBL2 | 1.90e-05 | 865 | 87 | 14 | int:HDAC2 |
| Interaction | AR interactions | KMT2C TNRC18 CYFIP1 PAXBP1 ABL1 ZBTB32 TCF20 INTS13 CTR9 UBTF SMARCA2 CHD4 GNAS SRCAP HNRNPU | 2.05e-05 | 992 | 87 | 15 | int:AR |
| Interaction | CHD3 interactions | H1-10 PAXBP1 CTR9 PRRC2C UBTF NOC3L SMARCA2 UBA3 CHD4 NOP2 HNRNPU MYBL2 FTSJ3 | 2.11e-05 | 757 | 87 | 13 | int:CHD3 |
| Interaction | ZBTB2 interactions | 2.40e-05 | 450 | 87 | 10 | int:ZBTB2 | |
| Interaction | ZRANB2 interactions | 2.47e-05 | 199 | 87 | 7 | int:ZRANB2 | |
| Interaction | NR2C2 interactions | SCAF1 H1-10 NAMPT PAXBP1 CTR9 NT5DC2 UBR4 NOC3L SMARCA2 PUS1 CHD1 CHD2 CHD4 NOP2 ZCCHC3 LARP7 HNRNPU FTSJ3 | 2.53e-05 | 1403 | 87 | 18 | int:NR2C2 |
| Interaction | SMARCB1 interactions | 2.75e-05 | 364 | 87 | 9 | int:SMARCB1 | |
| Interaction | H1-10 interactions | 2.84e-05 | 280 | 87 | 8 | int:H1-10 | |
| Interaction | ZBTB7B interactions | 2.87e-05 | 366 | 87 | 9 | int:ZBTB7B | |
| Interaction | JMJD6 interactions | 2.99e-05 | 205 | 87 | 7 | int:JMJD6 | |
| Interaction | PSIP1 interactions | 2.99e-05 | 205 | 87 | 7 | int:PSIP1 | |
| Interaction | OBSL1 interactions | SCAF1 H1-10 HMGA2 TCF20 UBTF CHD1 CHD4 HMGA1 SRCAP NOP2 LARP7 HNRNPU DHX8 FTSJ3 | 3.01e-05 | 902 | 87 | 14 | int:OBSL1 |
| Interaction | SOX2 interactions | H1-10 KMT2C TNRC18 TCF20 CTR9 UBTF ZNF644 UBR4 NOC3L SMARCA2 MLLT1 CHD4 NOP2 MECP2 LARP7 HNRNPU MYBL2 FTSJ3 | 3.02e-05 | 1422 | 87 | 18 | int:SOX2 |
| Interaction | SRSF1 interactions | SCAF1 PRRC2C NOC3L CHD4 MECP2 ZCCHC3 LARP7 HNRNPU DHX8 HDGF FTSJ3 | 3.37e-05 | 570 | 87 | 11 | int:SRSF1 |
| Interaction | RPL17 interactions | SCAF1 NOC3L CHD4 NOP2 MECP2 ZCCHC3 LARP7 HNRNPU DHX8 HDGF FTSJ3 | 3.42e-05 | 571 | 87 | 11 | int:RPL17 |
| Interaction | H2BC13 interactions | 3.48e-05 | 210 | 87 | 7 | int:H2BC13 | |
| Interaction | RBBP4 interactions | TNRC18 TCF20 STAG1 ARID4A SMARCA2 CHD4 HMGA1 MECP2 LARP7 HDGF MYBL2 | 3.53e-05 | 573 | 87 | 11 | int:RBBP4 |
| Interaction | MACROH2A2 interactions | 3.59e-05 | 211 | 87 | 7 | int:MACROH2A2 | |
| Interaction | CEBPB interactions | H1-10 NAMPT TCF20 CTR9 PRRC2C UBTF ZNF644 SMARCA2 MLLT1 AFF1 CHD4 HMGA1 TEF NOP2 HNRNPU MKNK1 DHX8 HDGF | 3.66e-05 | 1443 | 87 | 18 | int:CEBPB |
| Interaction | SRSF5 interactions | 3.73e-05 | 474 | 87 | 10 | int:SRSF5 | |
| Interaction | H1-3 interactions | 3.74e-05 | 291 | 87 | 8 | int:H1-3 | |
| Interaction | RSL1D1 interactions | 4.08e-05 | 479 | 87 | 10 | int:RSL1D1 | |
| Interaction | NANOG interactions | KMT2C KMT2B TCF20 STAG1 INTS13 UBTF SMARCA2 CHD4 HMGA1 ZCCHC3 | 4.23e-05 | 481 | 87 | 10 | int:NANOG |
| Interaction | TOP3B interactions | SCAF1 KMT2C TNRC18 NAMPT ABL1 KMT2B CASKIN1 UBR4 ANKRD11 MLLT1 GNAS KDM6B SRCAP NOP2 REXO1 CEP170B HNRNPU MYBL2 | 4.67e-05 | 1470 | 87 | 18 | int:TOP3B |
| Interaction | PURG interactions | 5.10e-05 | 223 | 87 | 7 | int:PURG | |
| Interaction | OASL interactions | 5.10e-05 | 223 | 87 | 7 | int:OASL | |
| Interaction | USP36 interactions | H1-10 PRRC2C NOC3L CHD1 CHD4 NOP2 ALKBH5 LARP7 HNRNPU DHX8 FTSJ3 | 5.28e-05 | 599 | 87 | 11 | int:USP36 |
| Interaction | CSNK2A1 interactions | HMGA2 KMT2B CTR9 PRRC2C UBTF ANKRD11 MLLT1 CHD4 HMGA1 ALKBH5 MECP2 LARP7 HDGF FTSJ3 | 5.67e-05 | 956 | 87 | 14 | int:CSNK2A1 |
| Interaction | ELF2 interactions | 5.88e-05 | 156 | 87 | 6 | int:ELF2 | |
| Interaction | DNAJC8 interactions | 6.20e-05 | 230 | 87 | 7 | int:DNAJC8 | |
| Interaction | YAP1 interactions | H1-10 KMT2C TNRC18 CYFIP1 ABL1 KMT2B TCF20 PRRC2C SCN1A SMARCA2 CHD1 CHD4 GNAS SRCAP HNRNPU | 6.38e-05 | 1095 | 87 | 15 | int:YAP1 |
| Interaction | H1-1 interactions | 6.56e-05 | 507 | 87 | 10 | int:H1-1 | |
| Interaction | HIPK2 interactions | 6.61e-05 | 98 | 87 | 5 | int:HIPK2 | |
| Interaction | SMC3 interactions | 6.66e-05 | 408 | 87 | 9 | int:SMC3 | |
| Interaction | SUPT5H interactions | 6.66e-05 | 408 | 87 | 9 | int:SUPT5H | |
| Interaction | CTR9 interactions | 6.72e-05 | 233 | 87 | 7 | int:CTR9 | |
| Interaction | EPHA1 interactions | 7.10e-05 | 235 | 87 | 7 | int:EPHA1 | |
| Cytoband | 16p12.2 | 5.39e-05 | 37 | 90 | 3 | 16p12.2 | |
| Cytoband | 16p11.2 | 5.61e-04 | 191 | 90 | 4 | 16p11.2 | |
| Cytoband | 10q23.33 | 9.36e-04 | 23 | 90 | 2 | 10q23.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 2.24e-03 | 278 | 90 | 4 | chr16p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 3.84e-03 | 159 | 90 | 3 | chr7q36 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 3.11e-04 | 9 | 54 | 2 | 1280 | |
| GeneFamily | Transcription elongation factor A like family | 3.11e-04 | 9 | 54 | 2 | 1216 | |
| GeneFamily | Canonical high mobility group | 4.73e-04 | 11 | 54 | 2 | 511 | |
| GeneFamily | PHD finger proteins | 2.46e-03 | 90 | 54 | 3 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.51e-03 | 25 | 54 | 2 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.62e-03 | 34 | 54 | 2 | 487 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | KMT2C TCF20 ARID4A PRRC2C ZNF644 SMARCA2 DYNC2I1 CHD1 CHD4 KDM6B CEP170B HNRNPU | 6.93e-08 | 467 | 90 | 12 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | KMT2C TCF20 ARID4A PRRC2C ZNF644 SMARCA2 DYNC2I1 CHD1 CHD4 KDM6B CEP170B HNRNPU | 1.02e-07 | 484 | 90 | 12 | MM999 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 7.20e-06 | 206 | 90 | 7 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 7.67e-06 | 208 | 90 | 7 | MM581 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | TNRC18 HMGA2 PRRC2C UBTF FAT3 ANKRD11 CHD2 KDM6B SRCAP MMP16 | 8.99e-06 | 413 | 89 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | KMT2C TNRC18 SORBS2 PRRC2C UBTF FAT3 SMARCA2 ANKRD11 CHD2 KDM6B SRCAP TEF MMP16 | 2.45e-05 | 790 | 89 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.90e-05 | 210 | 89 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.18e-05 | 230 | 89 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | XYLT2 H1-10 SORBS2 NAMPT HMGA2 NT5DC2 CHD1 SORBS1 HMGA1 SRRM3 NOP2 ZCCHC3 HNRNPU MYBL2 | 6.17e-05 | 991 | 89 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 6.19e-05 | 162 | 89 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.53e-05 | 249 | 89 | 7 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | TNRC18 SORBS2 PRRC2C UBTF FAT3 SMARCA2 ANKRD11 CHD2 KDM6B SRCAP TEF MMP16 | 1.20e-04 | 797 | 89 | 12 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | KMT2C TNRC18 SORBS2 PRRC2C UBTF FAT3 SMARCA2 ANKRD11 CHD2 KDM6B SRCAP MMP16 | 1.23e-04 | 799 | 89 | 12 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | KMT2C TNRC18 HMGA2 PRRC2C UBTF FAT3 SMARCA2 ANKRD11 CHD2 KDM6B SRCAP MMP16 | 1.26e-04 | 801 | 89 | 12 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | TNRC18 HMGA2 PRRC2C UBTF ANKRD11 CHD2 CHD4 KDM6B SRCAP MMP16 LARP7 MYBL2 | 1.34e-04 | 806 | 89 | 12 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.80e-04 | 281 | 89 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 3.05e-04 | 406 | 89 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.60e-04 | 315 | 89 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | KMT2C SORBS2 PRRC2C UBTF ANKRD11 CHD2 KDM6B SRCAP TEF MMP16 LARP7 | 4.83e-04 | 795 | 89 | 11 | gudmap_developingGonad_e16.5_ovary_1000 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.68e-09 | 197 | 90 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.95e-09 | 198 | 90 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.95e-09 | 198 | 90 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.23e-09 | 199 | 90 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.52e-09 | 200 | 90 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.52e-09 | 200 | 90 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.33e-07 | 193 | 90 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.52e-07 | 197 | 90 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.32e-06 | 171 | 90 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.29e-06 | 188 | 90 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 188 | 90 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.99e-06 | 197 | 90 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.08e-06 | 198 | 90 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.17e-06 | 199 | 90 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-05 | 162 | 90 | 5 | 64353d33af0e82ebb7cf2bba74d52ca0586a58fc | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-05 | 163 | 90 | 5 | 9f5facfa1864eb63e2f8022ad7379d9252b7a254 | |
| ToppCell | control-Plasmablast|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.13e-05 | 165 | 90 | 5 | 61063e0ce61bc92d5d1093be8279af03f650720b | |
| ToppCell | Healthy_donor-Plasmablast|World / disease group, cell group and cell class (v2) | 2.83e-05 | 175 | 90 | 5 | 5293e00fda63a291aa393bdf82ebd4b80265049f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.83e-05 | 175 | 90 | 5 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 177 | 90 | 5 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.99e-05 | 177 | 90 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-05 | 178 | 90 | 5 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-05 | 178 | 90 | 5 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 180 | 90 | 5 | 082c6116e0bbba8d9a3a82d14af55bdc8990c8c0 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 180 | 90 | 5 | 53043d764fad9ac33ee40e356e562e759931adef | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 3.41e-05 | 182 | 90 | 5 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.78e-05 | 186 | 90 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | (101)_plasma|World / immune cells in Peripheral Blood (logTPM normalization) | 3.78e-05 | 186 | 90 | 5 | 16267994c9ef1fb7118c4c665cbc96979ec2b703 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 187 | 90 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.08e-05 | 189 | 90 | 5 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 194 | 90 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 4.85e-05 | 196 | 90 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 4.97e-05 | 197 | 90 | 5 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.09e-05 | 198 | 90 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.09e-05 | 198 | 90 | 5 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.34e-05 | 200 | 90 | 5 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.34e-05 | 200 | 90 | 5 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O2-Trf|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 123 | 90 | 4 | 3b97ff4de1e16652291db1c9e2a8474675fcdbfe | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 123 | 90 | 4 | fd981879529ced0e3023a1f3f8794ce8ff4d99a8 | |
| ToppCell | VE-CD4-CD8_1|VE / Condition, Cell_class and T cell subcluster | 1.13e-04 | 123 | 90 | 4 | bc0f509716bb71d6e3fa343f4920ecb80eb62794 | |
| ToppCell | control-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.40e-04 | 130 | 90 | 4 | 9fe3c5be8488d341cff38757daf7856c112410d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 134 | 90 | 4 | e0f3ca643c206929203d80095663a5eac98ac088 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.62e-04 | 135 | 90 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.62e-04 | 135 | 90 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.76e-04 | 138 | 90 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-04 | 143 | 90 | 4 | 091708a47ac55c6585923ee30190ff296fa87f6f | |
| Disease | Neurodevelopmental Disorders | 8.39e-09 | 93 | 83 | 7 | C1535926 | |
| Disease | Intellectual Disability | KMT2C TCF20 STAG1 SCN1A PUS1 PACS2 GNAS KDM6B MECP2 LARP7 HNRNPU | 5.17e-08 | 447 | 83 | 11 | C3714756 |
| Disease | Mental Retardation, Psychosocial | 2.75e-06 | 139 | 83 | 6 | C0025363 | |
| Disease | Profound Mental Retardation | 2.75e-06 | 139 | 83 | 6 | C0020796 | |
| Disease | Mental deficiency | 2.75e-06 | 139 | 83 | 6 | C0917816 | |
| Disease | Epilepsy, Cryptogenic | 3.59e-06 | 82 | 83 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 3.59e-06 | 82 | 83 | 5 | C0751111 | |
| Disease | Aura | 3.59e-06 | 82 | 83 | 5 | C0236018 | |
| Disease | Epilepsy | 1.45e-05 | 109 | 83 | 5 | C0014544 | |
| Disease | Lennox-Gastaut syndrome | 1.16e-04 | 6 | 83 | 2 | C0238111 | |
| Disease | Adenoid Cystic Carcinoma | 1.86e-04 | 100 | 83 | 4 | C0010606 | |
| Disease | response to tamoxifen | 2.78e-04 | 9 | 83 | 2 | EFO_0009391 | |
| Disease | Liver Diseases, Parasitic | 2.78e-04 | 9 | 83 | 2 | C0023897 | |
| Disease | PITUITARY DWARFISM I | 2.78e-04 | 9 | 83 | 2 | C0342573 | |
| Disease | Myoclonic Astatic Epilepsy | 4.23e-04 | 11 | 83 | 2 | C0393702 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 5.07e-04 | 12 | 83 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.07e-04 | 152 | 83 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Precursor B-cell lymphoblastic leukemia | 1.59e-03 | 21 | 83 | 2 | C1292769 | |
| Disease | Autism Spectrum Disorders | 1.80e-03 | 85 | 83 | 3 | C1510586 | |
| Disease | sensory peripheral neuropathy, remission | 1.90e-03 | 23 | 83 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.07e-03 | 24 | 83 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.07e-03 | 24 | 83 | 2 | C3805278 | |
| Disease | mean platelet volume | 2.27e-03 | 1020 | 83 | 9 | EFO_0004584 | |
| Disease | Cholangiocarcinoma | 2.43e-03 | 26 | 83 | 2 | C0206698 | |
| Disease | response to antineoplastic agent | 2.77e-03 | 99 | 83 | 3 | GO_0097327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRDEERQKSKRGRPP | 656 | P29374 | |
| PRVLKDKSRDEGPRL | 1511 | Q6UB99 | |
| PGKKDARPREKLLGD | 1561 | Q6UB99 | |
| RDPALKPKRSHRKAD | 316 | Q6P6C2 | |
| KADKRRGPTPADRDR | 431 | Q9Y4F5 | |
| DSISEGKRPKKRGRP | 1101 | O14646 | |
| DRERERPVKAGKKKD | 456 | Q86XH1 | |
| GRPAEREAPDKKKAE | 231 | Q9Y6R0 | |
| EAEKPRKPKRQRAAE | 936 | Q92617 | |
| KRRRVGDVEPSRKPK | 1016 | Q92617 | |
| RSKPPEEEERKKRGR | 561 | Q9NVM9 | |
| KRRRVGDVEPSRKPK | 836 | F8W0I5 | |
| EKDPKSGFDIKVPRR | 536 | Q7L576 | |
| DTVKRRPKAKEREAG | 1146 | Q8WXD9 | |
| RKDGASPFQRARKKP | 41 | Q8NEZ4 | |
| REGKPRKEKPRKEER | 241 | Q96MG2 | |
| LNKDKGEKEERPRPQ | 96 | Q86YD7 | |
| RADKKPARGQKPEQR | 156 | Q92522 | |
| KDGRPLPARDKRALK | 256 | Q9NUN5 | |
| RRPREGRAKAKAKVP | 996 | O15054 | |
| RKPREPDRDNKHREK | 216 | Q8WVS4 | |
| AEEGKDHKRPKRPRT | 186 | Q8TE12 | |
| LEDRVRGPKGPEEKK | 481 | Q00839 | |
| RRAGDLLEDSPKRPK | 156 | P51858 | |
| RKKPLGERPKDEDER | 111 | Q4G0J3 | |
| KRRRVGDVEPSRKPK | 1041 | A8MRT5 | |
| KARRRLDKDALAPGP | 1136 | Q9UMN6 | |
| GNGLKPRKRPRENKE | 86 | Q9Y5B6 | |
| QPADRKRDAEKKDLP | 756 | Q86VP3 | |
| KRRRVGDVEPSRKPK | 1046 | C9JG80 | |
| EAEKPRKPKRQRAAE | 1076 | E5RHQ5 | |
| EPGDKASKKPSRGRR | 621 | Q8NC74 | |
| PDIRDREKKKGLFRP | 96 | Q96AV8 | |
| DGAPKDRTRKDGVPK | 476 | A6NNT2 | |
| SKGPRRLEKFPDEKA | 36 | Q6PKX4 | |
| EDSDDDKKPKRRGRP | 1106 | O14647 | |
| IKLPERDRKKRGEPI | 1261 | Q8TDW7 | |
| DDDETENGPKPKKRR | 971 | Q6PD62 | |
| KSEKPALPRKRAGEN | 756 | P00519 | |
| KKAEATGEKRPRGRP | 66 | P52926 | |
| DKAGPVPKGREDVKR | 86 | Q5BKX5 | |
| LRTKRKKPLPQERGD | 931 | P57679 | |
| EEAASPEGKRVPKRL | 206 | Q9HB96 | |
| RKLGEGRLPKEEKAP | 231 | Q03111 | |
| RPSRKGLRNDKDKPL | 1386 | Q14839 | |
| QLPRRPCAAGDKKKR | 21 | Q8N4B5 | |
| PPKDRKDRDKYGERN | 231 | Q14562 | |
| KLEPPRELRKRGEAA | 66 | Q9UBU6 | |
| KRRRVGDVEPSRKPK | 1046 | A6NJU9 | |
| RKPRGRPKKLEKEEE | 81 | P17096 | |
| NPKEKRPGKRIEREE | 66 | Q8WTT2 | |
| KAEADPQAIPKKRGR | 256 | P51608 | |
| SEPLPIADGDRRRKK | 16 | Q9BUB5 | |
| KSLFPVRDEKRGKRP | 1466 | Q9NQT8 | |
| DKGRGRPVEKPRADK | 401 | Q8N1G1 | |
| PKKPLSRDKDGEGRA | 526 | A6NNA2 | |
| PAKEDVEKAKKRRGR | 1356 | P51531 | |
| SGGDEERREKPPKRK | 71 | Q9Y606 | |
| DDIRPEKQKRKPGLR | 561 | P10244 | |
| PIKVSGAPDKRERAE | 336 | Q5JWF2 | |
| ERPEEKPKKEGFIRS | 961 | Q9Y520 | |
| LSKGKLPKREERPEN | 1281 | Q9Y520 | |
| EPLRGKKRSRGPKSD | 631 | Q8IY81 | |
| RAQPAKDRRAKGTPK | 26 | Q86UG4 | |
| PPREARLDKEKGKEK | 46 | Q10587 | |
| DPVADPNKRSKKGRL | 416 | P43490 | |
| KAKPPREKATDEGRR | 201 | Q15527 | |
| RSKKAKAPERPGTRV | 2381 | Q6ZRS2 | |
| DPTKEKRGPGRKARK | 6 | P46087 | |
| KVAERGKAKDADLRP | 31 | Q96JY6 | |
| ERRGTPEKEKLPAKA | 856 | O94875 | |
| ERRIAEEKAKNPKPD | 26 | P35498 | |
| KPAKPALKRSRREAD | 876 | P51825 | |
| PLSPRKDAGRAKDRK | 2031 | O15417 | |
| RPKDIGRPKAEVAAE | 116 | Q8TBC4 | |
| RAAGKRPAEDDVPRK | 111 | Q96EI5 | |
| RPAEDDVPRKAKRKT | 116 | Q96EI5 | |
| RRDPAGEAVDPRKKK | 101 | Q9NUD5 | |
| ARSARPKQDPKEGKR | 501 | Q96LT9 | |
| PKVGDPETRKAIRRA | 141 | P51512 | |
| KKEKAPERRVSAPAR | 326 | A8MU46 | |
| RDRDRSSKKARPPKE | 786 | Q9H7N4 | |
| EEGEKAKSPKLRLPR | 1321 | Q9BXM0 | |
| PGKAIEKRAKDDSRR | 351 | Q9BX66 | |
| LEETEVKGKRKRGRP | 26 | Q8WVM7 | |
| GKRPAEDDIPRKAKR | 126 | Q9H3H9 | |
| DRRKPFRKLDEKGSL | 306 | Q9H857 | |
| ADGEPKPKKQRQRRE | 1571 | Q9UGU0 | |
| KPDAKRPESFKDHRR | 791 | Q9H582 | |
| DEGLRPPKTKRASDK | 51 | Q5SQS7 | |
| RARGDRAKKPDPGLK | 111 | Q9Y2Y4 | |
| ERQLKDKFDGRPTKP | 286 | P17480 | |
| DKGKEKDPLAALRVR | 431 | Q5T4S7 | |
| DKKDLRHKPRETPGR | 166 | Q6IV72 | |
| DEAGEKGRQRKPRPL | 41 | Q9H1B5 |